Finder makes money from featured partners, but editorial opinions are our own.

How to buy Medibank (MPL) shares in Australia

Learn how to easily invest in Medibank shares.

Medibank is an insurance - specialty business based in Australia. Medibank shares (MPL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Medibank has a trailing 12-month revenue of around $7.9 billion. If you're looking to buy shares, check out the steps below.

How to buy shares in Medibank

To buy shares listed in Australia such as Medibank, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.

  1. Open and fund your brokerage account.
    Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  2. Search for Medibank.
    Find the share by name or ticker symbol: MPL. Research its history to confirm it's a solid investment against your financial goals.
  3. Purchase now or later.
    Buy today with a market order or use a limit order to delay your purchase until Medibank reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  4. Decide on how many to buy.
    At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  5. Check on your investment.
    Congratulations, you own a part of Medibank. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

Medibank stock price (ASX:MPL)

Use our graph to track the performance of MPL stocks over time.

Medibank shares at a glance

Information last updated 2024-07-12.
52-week range$3.2273 - $3.94
50-day moving average $3.6854
200-day moving average $3.649
Target price$3.88
PE ratio 15.9565
Dividend yield $0.155 (3.92%)
Earnings per share (TTM) $0.23

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Asset class
Finder AwardExclusive
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
Moomoo Share Trading
ASX shares, Global shares, US shares, ETFs
Get 10 free shares + earn 6.8% p.a. on idle cash upon deposit. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
Tiger Brokers
Tiger Brokers
ASX shares, Global shares, US shares, ETFs
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
CMC Invest
Finder Award
CMC Invest
ASX shares, Global shares, Options trading, US shares, ETFs
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
ASX shares, Global shares, Options trading, US shares, ETFs
Finder exclusive: Get an additional 30 days of $0 brokerage. Get advanced research and trading tools with $0 brokerage and free lvl 2 NASDAQ stock data for 30 days. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.

Is it a good time to buy Medibank stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Medibank price performance over time

Historical closes compared with the last close of A$3.67

1 week (2024-07-08) 0.82%
1 month (2024-06-14) -0.54%
3 months (2024-04-16) 0.82%
6 months (2024-01-16) -3.42%
1 year (2023-07-14) 9.55%
2 years (2022-07-15) 8.90%
3 years (2021-07-16) 12.23%
5 years (2019-07-16) 2.51%

Is Medibank under- or over-valued?

Valuing Medibank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medibank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medibank's P/E ratio

Medibank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Medibank shares trade at around 16x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Medibank's EBITDA

Medibank's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $966 million (£0.0 million).

The EBITDA is a measure of a Medibank's overall financial performance and is widely used to measure stock profitability.

Medibank financials

Revenue TTM $7.9 billion
Operating margin TTM 12.18%
Gross profit TTM $1.6 billion
Return on assets TTM 15.24%
Return on equity TTM 31.67%
Profit margin 8.63%
Book value 0.857
Market capitalisation $10.1 billion

TTM: trailing 12 months

Medibank's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medibank.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Medibank's total ESG risk score

Total ESG risk: 20.86

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medibank's overall score of 20.86 (as at 12/31/2018) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Medibank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Medibank's environmental score

Environmental score: 3.11/100

Medibank's environmental score of 3.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Medibank's social score

Social score: 10.91/100

Medibank's social score of 10.91 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Medibank's governance score

Governance score: 8.84/100

Medibank's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Medibank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Medibank's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Medibank scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Medibank has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Medibank Private Ltd was last rated for ESG on: 2019-01-01.

Total ESG score 20.86
Total ESG percentile 29.38
Environmental score 3.11
Environmental score percentile 1
Social score 10.91
Social score percentile 1
Governance score 8.84
Governance score percentile 1
Level of controversy 2

Medibank share dividends


Dividend payout ratio: 1.58% of net profits

Recently Medibank has paid out, on average, around 1.58% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.92% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medibank shareholders could enjoy a 3.92% return on their shares, in the form of dividend payments. In Medibank's case, that would currently equate to about A$0.155 per share.

While Medibank's payout ratio might seem low, this can signify that Medibank is investing more in its future growth.

The latest dividend was paid out to all shareholders who bought their shares by 28 February 2024 (the "ex-dividend date").

Medibank share price volatility

Over the last 12 months, Medibank's shares have ranged in value from as little as $3.2273 up to $3.94. A popular way to gauge a stock's volatility is its "beta".

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Medibank's is 0.182. This would suggest that Medibank's shares are less volatile than average (for this exchange).

Medibank overview

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask a Question

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms Of Service and Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site